Speakers Confirmed for Hayes 2017 Client Symposium

We are pleased to announce our lineup of guest speakers for this year’s Client Symposium. In addition to our keynote speaker, we are featuring two professionals who bring years of healthcare expertise and experience to our second annual gathering in the city of brotherly love.

The credentials of these sought-after presenters speak for themselves, so I’m going to let them do just that. Once you’ve read about their impressive backgrounds and accomplishments, head over to our registration page and reserve your spot at the Client Symposium today!

Read More

Topics: Payers, Hayes Blog

NPR Segment Features Treatments for Low Back Pain

Last week, as part of their “Your Health” segment, NPR aired a piece about the effectiveness of various treatments for low back pain, with a focus on spinal manipulation. Lower back pain is a common complaint to physicians, and, as the article states, a common reason for the prescription of addictive narcotic painkillers. Other interventions can include:

  • Acupuncture
  • Physical therapy
  • Massage therapy
  • Nonsteroidal anti-inflammatory drugs (NSAIDS)
  • Chiropractic treatment
Read More

Topics: Payers, Hospitals, Hayes Blog, Devices, Health Technology Assessments,

Top 3 Hayes Reports: 1st Quarter, 2017

Who doesn’t love lists? Especially lists detailing the best of the best, the most popular, the most in-demand. To that end, we’ve compiled a list of our top three Directory reports for the first three months of the year, in order of retrievals from our Knowledge Center. These three represent a mix of information important to both payers and providers.

If you’re already a subscriber, you can check out these reports at any time. If you’re not a Hayes member…what are you waiting for? Don’t forget, you can also purchase an individual report. Contact us to find out how.

Let’s get to the top three!

Read More

Topics: Payers, Hospitals, Hayes Blog, Health Technology Assessments,

On the Horizon: CAR T-Cell Therapy for Cancer Treatment

Traditional cancer treatments include procedures with which we’re all familiar: chemotherapy, surgery, and radiation therapy. But clinicians and scientists continue to work tirelessly to find a cure for the devastating disease. While immunotherapy has been in the news as of late as relates to the treatment of peanut allergies (see our blog, Peanut Allergy Drug Therapies Make National Headlines), there have been advances in its use for the treatment of cancer over the past few years. There are several biologic agents that are FDA approved for different cancers; these targeted therapies are aimed at destroying cancer cells without the troublesome side effects that accompany traditional cancer treatments.  

But there’s something new on the horizon from the world of immunotherapy.

Read More

Topics: Health Technologies, Payers, Hospitals, Hayes Blog

Does Evidence Have a Role in Treating the Opioid Epidemic?

America has an opioid problem.

According to a 2016 report from the American Society of Addiction Medicine (ASAM), drug overdose is the leading cause of accidental death in the U.S., with 52,404 lethal drug overdoses in 2015. Of that number, 20,101 overdose deaths were related to prescription opioid pain relievers and 12,990 overdose deaths were related to heroin in 2015. In 2012, 259 million prescriptions were written for opioids; 80% of new heroin users began by misusing prescription painkillers. 

Read More

Topics: Health Technologies, Payers, Hospitals, Hayes Blog

3 Questions with Dr. Nierman of Tufts Health Plan

Posted by The Evidence Blog on February 27, 2017

This week, we were fortunate enough to have a conversation with Dr. Nierman of Tufts Health Plan, located in Watertown, MA. The Tufts Health Plan is a nonprofit organization, founded in 1979, that is nationally recognized for its commitment to providing innovative, high-quality healthcare coverage. The plan offers members and employers an array of health management programs, which support evidence-based approaches to health and wellness. Dr. Nierman has served as the Medical Director for Medical Policy for more than 18 years, and took the time to speak with us regarding why the plan made the decision to subscribe to Hayes for our unbiased evidence evaluations to better serve their health plan members.

Read More

Topics: Health Technologies, Payers, Hayes Blog, Health Technology Assessments,

The 2017 Second Annual Hayes Client Symposium

After the rousing success of our inaugural client symposium, it only made sense to have it become an annual affair. We’re happy to announce that both the date and location have been confirmed for the second Hayes, Inc. Client Symposium!

As with our maiden event, the Hayes Client Symposium is an opportunity for our health plan clients to learn about current and future trends in the industry, including the ability to earn continuing education credits with two accredited sessions. Additionally, both at dinner and during scheduled breakouts, clients will have the opportunity to network both with Hayes employees as well as with each another.

Read More

Topics: Payers, Hayes Blog

We’ve Got Your Back: Earn CE Credits with Our Vertebral Compression Fracture Webinar

Posted by Paula Goines, PhD, Medical Research Analyst on February 16, 2017

Meaning “porous bone,” osteoporosis occurs when the body loses or makes too little bone. The appearance of osteoporotic bone under a microscope does not reveal the traditional dense “honeycomb” pattern that gives the bone stability. Instead, the patterns are almost web-like, with large holes where smaller ones would normally be, causing the bone to be quite fragile. Depending on the severity of the condition, incidents as severe as a fall to as minor as a cough can cause bones to fracture, most commonly the vertebrae (spine). And unfortunately, chances are good you know or have known someone suffering from one of these fractures.

Read More

Topics: Payers, Hayes Blog, Devices, Health Technology Assessments,

Analytical Validity, Clinical Validity, and Clinical Utility: What’s the Difference?

Posted by The Evidence Blog on February 7, 2017

Genetic testing is seemingly everywhere today. No longer are discussions of tumor profiling, gene panels, genomics and proteomics confined to the scientific realm. Major news outlets cover new advances in genetic testing, as well as some of the hidden risks associated with their exponential growth in the consumer market (See our blog Evidence Shines a Light on the Hidden Dangers of Genetic Testing). Technical innovations, such as next-generation sequencing, have accelerated the development of such tests. Consequently, there is increasing demand on you as both physicians and payers to provide your patients and clients with the best possible test solutions. But how do you decide? There are three essential criteria to consider when making your determinations regarding genetic testing.

Read More

Topics: Payers, Hospitals, Hayes Blog, Healthcare Evidence, Genetic Testing

FDA Approves New Treatment for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic disorder characterized by loss of motor neurons, leading to weakness and wasting of muscles used for activities such as crawling, walking, sitting up, and controlling head movement. In severe cases of SMA, the muscles used for breathing and swallowing are affected. This devastating disorder affects approximately 1 in 10,000 births and is the most common genetic cause of infant mortality. SMA is caused by deletions or mutations in a gene that leads to a deficiency of survival motor neuron (SMN) protein; this protein is critical for the maintenance of motor neurons. The severity of SMA is directly related to the amount of SMN protein.

Read More

Topics: Health Technologies, Payers, Hospitals, Government, Hayes Blog